- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00709631
Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers (ULCERE)
February 24, 2015 updated by: Assistance Publique - Hôpitaux de Paris
Prospective Evaluation of the Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers
Primary aim of the study : to evaluate the prevalence of ulcerated cutaneous carcinoma or malignant degeneration, in leg ulcers, presumed of vascular origin and without evidence of healing despite 3 months of adequate treatmentSecondary aims of the study : to evaluate the interest of immunostainings for desmogleins 1-2 and p16 on biopsies to differentiate between pseudo epitheliomatous hyperplasia and squamous cell carcinoma ; and the prognosis of diagnosed carcinomas at 12 monthsStudy hypothesis : systematic biopsies of hard-to-heal leg ulcer may help to detect ulcerated carcinomas misdiagnosed as vascular ulcer or malignant degeneration of leg ulcer.
Study Overview
Status
Completed
Conditions
Detailed Description
Prospective multicentric inclusion of 150 patients with leg ulcers without any evidence of healing (no change or increase of ulcer area) despite 3 months of adequate treatment The study population consisted of consecutive patients with one or more leg ulcers, diagnosed as related to venous insufficiency, associated or not with concomitant arterial insufficiency.
All patients undergo a standard treatment including compression therapy adapted to the ankle brachial index and a local treatment depending on the wound stage.At inclusion, systematic punch biopsies (5-6 mm) are taken as part of routine clinical care under local anaesthetic by an experienced clinician: 1 to 2 biopsies in the edges and 1 to 2 biopsies in the wound bedSpecimens are transported in formalin solution to the usual pathology laboratory of the investigator.
At the end of the study, specimens will be sent for immunostainings in a single pathology laboratory (Rouen, France)Treatments and/or other investigations are decided by the investigatorAt 12 months of usual follow-up, final diagnosis and prognosis are noted in the study file by the investigator.
Study Type
Observational
Enrollment (Actual)
155
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ile de France
-
Ivry sur Seine, Ile de France, France, 94205
- Patricia SENET, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with one or more leg ulcers, diagnosed as related to venous insufficiency, associated or not with concomitant arterial insufficiency.
Description
Inclusion Criteria:
- leg ulcer of more than 3 months of duration
- leg ulcer presumed of vascular origin
- adequate etiologic treatment since 3 months
- absence of evidence of healing : absence of reduction of wound area or increase in wound area and/or in depth
Exclusion Criteria:
- hypertensive ulcer
- vasculitis
- treatment by cytotoxic agents or steroids in the previous 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Patricia SENET, MD, AP-HP, Hôpital Charles Foix, 94205 Ivry/Seine, France et Hôpital Tenon, 75020 Paris, France
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2006
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
May 1, 2010
Study Registration Dates
First Submitted
July 2, 2008
First Submitted That Met QC Criteria
July 2, 2008
First Posted (Estimate)
July 3, 2008
Study Record Updates
Last Update Posted (Estimate)
February 25, 2015
Last Update Submitted That Met QC Criteria
February 24, 2015
Last Verified
June 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00006477 (IRB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Leg Ulcers
-
Venenklinik BellevueCompleted
-
Macrocure Ltd.UnknownChronic Venous Leg UlcersUnited States
-
Kringle Pharma Europe ABKringle Pharma, Inc.UnknownChronic Venous Leg UlcersNorway, Sweden
-
Osiris TherapeuticsTerminated
-
Ohio State UniversityNational Institute on Aging (NIA)RecruitingChronic Venous Leg UlcersUnited States
-
Kingfisher HealthcareUnknownChronic Venous Leg UlcersBelgium
-
PhotopharmicaCompletedWound Healing | Chronic Leg UlcersUnited Kingdom
-
Professor Stewart WalshCompletedChronic Venous DiseaseIreland
-
SoftOx Solutions ASCompletedVenous Leg Ulcer | Chronic Leg UlcerDenmark
-
Fisher and Paykel HealthcareRecruiting